عرض تفاصيل البحث

ادناه جميع التفاصيل الخاصة بالبحث المطلوب عرضه. توفر هذه المنصة معلومات اساسية حول البحث, لمزيد من التفاصيل يرجى متابعة التصفح من خلال الضغط على الرابط الاصلي للبحث او رابط DOI.

عنوان البحث
Prevalence Of Adverse Effects From Covid-19 Vaccine Among Iraqi Adults: A Retrospective Cross-Sectional Study
عنوان المجلة
Journal Of Emergency Medicine
ISSN-0736-4679
تفاصيل النشر
سنة النشر - 2022 / الفهرس الاصلي للمجلة - 3 : 6 (عدد الصفحات 9)
تصنيف البحث
الطب - المجموعة الطبية
رابط DOI
https://doi.org/10.5339/jemtac.2022.ismc.6
رابط البحث
فتح في موقع المجلة الرسمي
البحث والاستدامة
الهدف 3 – الصحة الجيدة والرفاه   المزيد حول هذا الهدف
البحث والمجتمع
نعم , يدعم
الكلمات المفتاحية
adverse effects, Pfizer, vaccine, Sinopharm, AstraZeneca, COVID-19

اسم الباحثجهة الانتساببلد الباحث
امل طالب السعدي كلية الصيدلة العراق
حيدر عبد الامير مكي كلية الصيدلة العراق

Background: The production of a successful vaccine has become a global dream since the declaration of coronavirus disease 2019 (COVID-19) as a global pandemic by the World Health Organization. However, doubts abound about vaccine safety. In this study, we aimed to estimate and compare the prevalence of adverse effects in Iraqi adults from the COVID-19 vaccines used in Iraq. Methods: The study was a retrospective, cross-sectional study conducted in August 2021. An online-based questionnaire was applied randomly and distributed to individuals ( 18 years). Results: Among the 1000 vaccinated participants from different regions in Iraq, 66.0% were from middle Euphrates, 61.3% were women, and 62.2% were in their third to fifth decade of life. Approximately, 68.4% of the participants received Pfizer vaccine, and 42.5% had a previous history of COVID-19 infection Figure 1. Most of the participants (84.1%) suffered general adverse effects after vaccination, including (in sequence of appearance) fatigue, fever, headache, injection site signs, and axillary pain. Most studied factors have no significant correlation with post-vaccine adverse effects (P 0.05) such as age, sex, history of COVID-19 infection, and chronic disease. There was a significant correlation between adverse effects from the vaccine dose and age of recipients. Those with a history of comorbidities had a two-fold risk of developing adverse effects.